CDC acting director blocked Covid vaccine study; findings published in JAMA Network Open
By
Aria Bendix
Summary
A study on Covid vaccines that was blocked from publication by the CDC's acting director, Jay Bhattacharya, was published in JAMA Network Open instead. The study found that Covid vaccines reduced the likelihood of severe illness by about half among adults during the fall and winter seasons. The research was originally slated for release in the CDC's Morbidity and Mortality Weekly Report (MMWR) but was blocked, leading to its publication in an outside peer-reviewed journal.
Source
Key quotes
· 3 pulledThe findings show that Covid vaccines reduced the likelihood of severe illness by about half among adults last fall and winter.
The study was originally scheduled to be released in March in the CDC's flagship scientific publication, the Morbidity and Mortality Weekly Report (MMWR).
Instead, it was published in JAMA Network Open, a highly regarded, peer-reviewed journal from the American Medical Association.
You might also wanna read
CDC Modifies Position on Vaccines and Autism Under Kennedy's Leadership
The article discusses how the CDC, under the direction of Health and Human Services Secretary Robert F. Kennedy Jr., has modified its longst
Undisclosed Deaths in the Pfizer mRNA Covid-19 Vaccine Trial [pdf]

FDA Official Requests Removal of YouTube Videos Showing His COVID Vaccine Criticism
A top FDA official, Vinay Prasad, demanded YouTube remove videos of himself criticizing COVID-19 vaccines from a physician's channel. Jonath

HHS Ends mRNA Vaccine Development Under BARDA Following Review
The U.S. Department of Health and Human Services (HHS) has announced the wind-down of its mRNA vaccine development activities under BARDA, i

Study Examines Association Between mRNA COVID-19 Vaccination and 4-Year All-Cause Mortality in French Adults Aged 18-59
This cohort study analyzes data from over 28 million French adults aged 18-59 to examine the association between mRNA COVID-19 vaccination a
Kennedy guts CDC's vaccine panel of independent experts
Comments
Sign in to join the conversation.
No comments yet. Be the first.
